Journal Articles Conference Presentations Book Chapters Public Presentations

Revisiting the mouse lung model for CF.

Boyd AC, Porteous DJ

Gene Therapy

Gene Ther. 2004 May;11(9):737-8.

Print this page

Go Back to Publications     View on Pubmed (14999230)    View on Google Scholar


 

Other Publications by these authors
Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung.
Alton EW et al. Gene Therapy (2013) A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis.
Alton EW et al. Thorax (2013) Sputum and serum calprotectin are useful biomarkers during CF exacerbation.
Gray RD et al. Journal Of Cystic Fibrosis : Official Journal Of The European Cystic Fibrosis Society (2010) The effects of plasmid copy number and sequence context upon transfection efficiency.
Walker WE et al. Journal Of Controlled Release : Official Journal Of The Controlled Release Society (2003) Insertion of natural intron 6a-6b into a human cDNA-derived gene therapy vector for cystic fibrosis improves plasmid stability and permits facile RNA/DNA discrimination.
Boyd AC et al. The Journal Of Gene Medicine (2000) pSURF-2, a modified BAC vector for selective YAC cloning and functional analysis.
Boyd AC et al. BioTechniques (1999)